PT - JOURNAL ARTICLE AU - Hyun Yi AU - Shue Liu AU - Yuta Kashiwagi AU - Daigo Ikegami AU - Wan Huang AU - Hirotsugu Kanda AU - Takafumi Iida AU - Ching-Hang Liu AU - Keiya Takahashi AU - David A. Lubarsky AU - Shuanglin Hao TI - Phosphorylated CCAAT/enhancer binding protein β contributes to rat HIV-related neuropathic pain, <em>in vitro</em> and <em>in vivo</em> studies AID - 10.1523/JNEUROSCI.3647-16.2017 DP - 2017 Dec 01 TA - The Journal of Neuroscience PG - 3647-16 4099 - http://www.jneurosci.org/content/early/2017/12/01/JNEUROSCI.3647-16.2017.short 4100 - http://www.jneurosci.org/content/early/2017/12/01/JNEUROSCI.3647-16.2017.full AB - Chronic pain is increasingly recognized as an important comorbidity of HIV-infected patients, however, the exact molecular mechanisms of HIV-related pain are still elusive. CCAAT/enhancer binding proteins (C/EBPs) are expressed in various tissues, including the central nervous system. C/EBPβ, one of C/EBPs is involved in the progression of HIV/AIDS, but the exact role of C/EBPβ and its upstream factors are not clear in HIV pain state. Here, we used a neuropathic pain model of perineural HIV envelope glycoprotein gp120 application onto the rat sciatic nerve to test the role of phosphorylated C/EBPβ (pC/EBPβ) and its upstream pathway in the spinal cord dorsal horn (SCDH). HIV gp120 induced over-expression of pC/EBPβ in the ipsilateral SCDH compared to contralateral SCDH. Inhibition of C/EBPβ using siRNA against C/EBPβ reduced mechanical allodynia. HIV gp120 also increased TNFα, TNFRI, mitochondrial superoxide (mtO2•-), and pCREB in the ipsilateral SCDH. ChIP-qPCR assay showed that pCREB enrichment on the C/EBPβ gene promoter regions in rats with gp120 was higher than that in sham rats. Intrathecal TNF soluble receptor I (functionally blocking TNFα bioactivity) or knockdown of TNFRI using antisense oligodeoxynucleotide against TNFRI reduced mechanical allodynia, and decreased mtO2•-, pCREB and pC/EBPβ. Intrathecal Mito-tempol (a mitochondria-targeted O2•- scavenger) reduced mechanical allodynia and decreased pCREB and pC/EBPβ. Knockdown of CREB with antisense oligodeoxynucleotide against CREB reduced mechanical allodynia and lowered pC/EBPβ. These results suggested that the pathway of TNFα/TNFRI—mtO2•-—pCREB triggers pC/EBPβ in the HIV gp120-induced neuropathic pain state. Furthermore, we confirmed the pathway using both cultured neurons treated with recombinant TNFα in vitro and repeatedly intrathecal injection of recombinant TNFα in naïve rats. This finding provides new insights in the understanding of the HIV neuropathic pain mechanisms and treatment.Significance statementPainful HIV-associated sensory neuropathy is a neurological complication of HIV infection. Phosphorylated C/EBPβ (pC/EBPβ) influences AIDS progression, but it is still not clear about the exact role of pC/EBPβ and the detailed upstream factors of pC/EBPβ in HIV-related pain. In a neuropathic pain model of perineural HIV gp120 application onto the sciatic nerve, we found that pC/EBPβ was triggered by TNFα/TNFRI—mtO2•-—pCREB signaling pathway. The pathway was confirmed by using cultured neurons treated with recombinant TNFα in vitro, and by repeatedly intrathecal injection of recombinant TNFα in naïve rats. The present results revealed the functional significance of TNFα/TNFRI—mtO2•-—pCREB—pC/EBPβ signaling in HIV neuropathic pain, and should help in the development of more specific treatments for neuropathic pain.